J. Biskupiak

发表

The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy

D. Brixner, E. Biltaji, A. Bress, 2016, Journal of medical economics.

Application of electronic medical record data for health outcomes research: a review of recent literature

Carrie McAdam-Marx, C. McAdam-Marx, J. Biskupiak, 2013, Expert review of pharmacoeconomics & outcomes research.

Absolute configuration of thiazole amino acids in peptides

C. Ireland, J. Biskupiak, 1983 .

Value Assessment for Genetic Testing of Drug Variation In An Elderly Population.

D. Brixner, E. Biltaji, A. Bress, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective

Anand A. Dalal, D. Brixner, J. Biskupiak, 2018, Journal of managed care & specialty pharmacy.

Hemorrhagic and Thrombotic Events Associated with Generic Substitution of Warfarin in Patients with Atrial Fibrillation: A Retrospective Analysis

E. S. Fox, Xiangyang Ye, D. Brixner, 2011, The Annals of pharmacotherapy.

PHARMACOECONOMICS AND OUTCOMES IN PAIN AND PALLIATIVE CARE A Cost-Utility Analysis of Pregabalin Versus Duloxetine for the Treatment of Painful Diabetic Neuropathy

B. Bellows, J. Biskupiak, Arati Dahal, 2012 .

Cost Effectiveness Analysis Of Mri Guided Ablation Based On The Decaaf Trial

N. Marrouche, J. Biskupiak, M. Singhal, 2014 .

BRCA testing and outcomes in women with breast cancer

R. Deka, D. Brixner, H. Bauer, 2021, Breast Cancer Research and Treatment.

Current issues in comparative effectiveness research for hepatitis C

J. Biskupiak, M. Yoo, Yan Cheng, 2014 .

Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer.

D. Gaffney, J. Biskupiak, N. Nickman, 2015, The Journal of community and supportive oncology.

Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid.

D. Gaffney, J. Biskupiak, N. Nickman, 2013, Breast.

Table of Contents “ This Drug May Work , But Is It Worth the Cost ? ” Can Comparative Effectiveness Research Help Tame Rising Health Care Costs ?

John B. Watkins, A. Holtorf, D. Brixner, 2012 .

Implementing CER: what will it take?

A. Holtorf, J. Biskupiak, J. Dunn, 2012, Journal of managed care pharmacy : JMCP.

Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.

Kensaku Kawamoto, K. Nolen, T. Kannampallil, 2022, Future cardiology.

Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation.

N. Marrouche, D. Brixner, J. Biskupiak, 2016, The American journal of managed care.

Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.

Frederick T. Han, E. Kholmovski, N. Marrouche, 2017, Journal of the American College of Cardiology.

Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: A retrospective cohort study.

J. Fang, J. Biskupiak, K. Shah, 2022, Journal of cardiac failure.

Tetrodotoxin‐Sensitive Neuronal‐Type Na+ Channels: A Novel and Druggable Target for Prevention of Atrial Fibrillation

Megan L. Koleske, S. Priori, C. Carnes, 2020, Journal of the American Heart Association.

Assessing the value of hospice care: is documentation of cost savings necessary.

J. Biskupiak, E. Korner, 2005, Journal of pain & palliative care pharmacotherapy.

Chronic Constipation: Overview and Treatment Options

J. Biskupiak, A. Tuteja, 2007 .

Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality

M. Munger, J. Biskupiak, N. Nickman, 2022, Pharmacotherapy.

The Role of Pharmacoeconomics in Formulary Management:Triptan Case Study for Migraine

V. Joish, J. Biskupiak, M. Ho, 2005 .

All-Cause and Bleeding-Related Health Care Costs in Warfarin-Treated Patients with Atrial Fibrillation

Joseph Biskupiak, Xiangyang Ye, D. Brixner, 2011, Journal of managed care pharmacy : JMCP.

The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates.

C. Tak, J. Biskupiak, Catherine M Sherwin, 2019, Vaccine.

Cyclic peptide structures from the tunicate Lissoclinum patella by FAB mass spectrometry

C. Ireland, C. Costello, J. Biskupiak, 1983 .

Cytotoxic metabolites from the mollusc peronia peronii

C. Ireland, J. Biskupiak, 1985 .

Ilikonapyrone esters, likely defense allomones of the mollusk Onchidium verruculatum

C. Ireland, G. Hite, P. Scheuer, 1984 .

Radiosynthesis of 6-[C-11]-D-glucose.

K. Krohn, J. Grierson, J. Link, 1993, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

All-Cause and Incremental Per Patient Per Year Cost Associated with Chronic Hepatitis C Virus and Associated Liver Complications in the United States: A Managed Care Perspective

C. McAdam-Marx, D. Brixner, J. Biskupiak, 2011, Journal of managed care pharmacy : JMCP.

Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center.

D. Brixner, T. Kovacsovics, D. Stenehjem, 2019, Leukemia research.

Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States

D. Brixner, J. Biskupiak, Zheng-Yi Zhou, 2021, Journal of medical economics.

Methodological Challenges of Comparative Effectiveness Research in Pain: Implications for Investigators, Clinicians, and Policy Makers

B. Bellows, J. Biskupiak, 2011, Journal of pain & palliative care pharmacotherapy.

PHARMACOECONOMICS AND OUTCOMES IN PAIN & PALLIATIVE CARE Methodological Challenges of Comparative Effectiveness Research in Pain: Implications for Investigators, Clinicians, and Policy Makers

B. Bellows, J. Biskupiak, 2011 .

Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis

J. Biskupiak, Dave Young, D. Brixner, 2022, Pulmonary medicine.

Muamvatin, a novel tricyclic spiro ketal from the Fijian mollusc Siphonaria normalis

C. Ireland, J. Biskupiak, D. Roll, 1986 .

Pectinatone, a new antibiotic from the mollusc siphonaria pectinata

C. Ireland, J. Biskupiak, 1983 .

Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect Comparison

J. Biskupiak, N. Chaiyakunapruk, A. Kharat, 2021, Oncology Research and Treatment.

Cost-Sharing Requirements for the Herpes Zoster Vaccine in Adults Aged 60+

C. Tak, J. Biskupiak, Catherine M Sherwin, 2019, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

E. Kholmovski, C. McGann, G. Stoddard, 2016, The American journal of cardiology.

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation

D. Brixner, J. Biskupiak, T. Jiao, 2013, Journal of managed care pharmacy : JMCP.

Statin use and mortality in rheumatoid arthritis: an incident user cohort study.

J. Biskupiak, A. Chhibber, S. Hansen, 2021, Journal of managed care & specialty pharmacy.

Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi’s sarcoma

M. Goodman, C. Asche, J. Biskupiak, 2013, Journal of medical economics.

Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes

Kibum Kim, J. Biskupiak, Jennifer L. Babin, 2022, Healthcare.

Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.

K. Krohn, J. Rasey, J. Grierson, 1991, Journal of medicinal chemistry.

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.

D. Brixner, J. Biskupiak, G. Oderda, 2006, Journal of pain & palliative care pharmacotherapy.

Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center

M. Munger, D. Brixner, A. Bress, 2016, Pharmacotherapy.

Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system

D. Brixner, J. Biskupiak, T. Giannouchos, 2020, The American Journal of Emergency Medicine.

Effect of Inpatient Dobutamine versus Milrinone on Out‐of‐Hospital Mortality in Patients with Acute Decompensated Heart Failure

M. Munger, A. Bress, J. Biskupiak, 2017, Pharmacotherapy.

Antiplatelet medication management in patients hospitalized with ischemic stroke.

D. Brixner, J. Biskupiak, N. Nickman, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A Cost-Utility Analysis of Pregabalin Versus Duloxetine for the Treatment of Painful Diabetic Neuropathy

B. Bellows, J. Biskupiak, Arati Dahal, 2012, Journal of pain & palliative care pharmacotherapy.

Prevalence of High‐Risk Cardiovascular Conditions and the Status of Hypertension Management Among Hypertensive Adults 65 Years and Older in the United States: Analysis of a Primary Care Electronic Medical Records Database

J. Biskupiak, Jaewhan Kim, David Wu, 2010, Journal of clinical hypertension.

Blood Pressure Outcomes in Patients Receiving Angiotensin II Receptor Blockers in Primary Care: A Comparative Effectiveness Analysis From Electronic Medical Record Data

K. Ramaswamy, J. Biskupiak, A. Ryan, 2011, Journal of clinical hypertension.

Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States.

S. Unni, X. Ye, J. Biskupiak, 2016, Journal of clinical lipidology.

SCREENING OF PATIENTS AT RISK FOR WILD TYPE ATTR-CM USING A COMPUTATIONAL MACHINE LEARNING ALGORITHM

Kensaku Kawamoto, J. Biskupiak, J. Nativi-Nicolau, 2021, Journal of the American College of Cardiology.

Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain

A. Lipman, J. Biskupiak, G. Stoddard, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment.

J. Biskupiak, Niying Li, S. Slager, 2023, Journal of managed care & specialty pharmacy.

Original research Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma

M. Goodman, C. Asche, J. Biskupiak, 2013 .

Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2− advanced or metastatic breast cancer

Anand A. Dalal, D. Brixner, R. Hettle, 2018, Current medical research and opinion.

Revised absolute configuration of dysidenin and isodysidenin

C. Ireland, J. Biskupiak, 1984 .

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab.

S. Feldman, D. Brixner, J. Biskupiak, 2019, American health & drug benefits.

Role Of Glycemic Control In Development Of Atrial Fibrillation In Patients With Type 2 Diabetes Mellitus

R. Nelson, C. McAdam-Marx, D. Witt, 2016 .

Economic analysis of "liquid" versus surgical face-lift: are large-volume facial soft tissue filler injection treatments a viable alternative to rhytidectomy?

A. Sclafani, J. Biskupiak, 2010, Facial plastic surgery : FPS.

Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

Anand A. Dalal, D. Brixner, J. Biskupiak, 2019, Journal of managed care & specialty pharmacy.

Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis

R. Kadish, J. Biskupiak, S. Clardy, 2021, Journal of Neuroimmunology.

“This Drug May Work, But Is It Worth the Cost?” Can Comparative Effectiveness Research Help Tame Rising Health Care Costs?

John B. Watkins, A. Holtorf, D. Brixner, 2015 .

Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials.

R. Nelson, J. Biskupiak, A. Kharat, 2021, Journal of Managed Care & Specialty Pharmacy.

Patient Compliance and its Impact on Treatment Outcomes

L. Pizzi, J. Biskupiak, 1999 .

Cyclic peptide structures from the tunicate Lissoclinum patella by FAB mass spectrometry

C. Ireland, C. Costello, J. Biskupiak, 1983 .

Payer perceptions on the use of economic models in oncology decision making

B. Arondekar, J. Biskupiak, G. Oderda, 2021, Journal of managed care & specialty pharmacy.

Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies.

P. Neumann, D. Brixner, J. Biskupiak, 2019, Journal of Managed Care & Specialty Pharmacy.

Payer perceptions of the use of real-world evidence in oncology-based decision making

D. Malone, B. Arondekar, J. Biskupiak, 2021, Journal of managed care & specialty pharmacy.

Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia.

K. Krohn, J. Rasey, G. Martin, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Statin use and mortality in rheumatoid arthritis: an incident user cohort study

J. Biskupiak, A. Chhibber, Savannah Hansen, 2020, Journal of managed care & specialty pharmacy.

Gastrointestinal Complications of Over-the-Counter Nonsteroidal Antiinflammatory Drugs

D. Brixner, J. Biskupiak, G. Oderda, 2006 .

Second generation hypoxia imaging agents.

K. Krohn, J. Biskupiak, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Blood Pressure Outcomes in Patients Receiving Angiotensin II Receptor Blockers in Primary Care: A Comparative Effectiveness Analysis From Electronic Medical Record Data

K. Ramaswamy, J. Biskupiak, A. Ryan, 2011, Journal of clinical hypertension.

J. Biskupiak, Jaewhan Kim, David Wu, 2010, Journal of clinical hypertension.

Would Depression Management Relieve Pain and Improve Function?

J. Biskupiak, M. Ho, 2005 .

Would depression management relieve pain and improve function.

J. Biskupiak, M. Ho, 2004, Journal of pain & palliative care pharmacotherapy.

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

Colin D J Hopley, Daniel C Swift, G. Forlenza, 2023, Journal of managed care & specialty pharmacy.

Application of electronic medical record data for health outcomes research: a review of recent literature

C. McAdam-Marx, J. Biskupiak, Junji Lin, 2013, Expert review of pharmacoeconomics & outcomes research.

Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center

M. Munger, D. Brixner, A. Bress, 2016, Pharmacotherapy.

Decision Analysis: A Primer and Application to Pain-Related Studies

R. Nelson, J. Biskupiak, Jaewhan Kim, 2008, Journal of pain & palliative care pharmacotherapy.

Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain

A. Lipman, J. Biskupiak, G. Stoddard, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

OUTCOMES AND ECONOMICS IN PAIN & PALLIATIVE CARE

J. Biskupiak, M. Ho, 2004 .